Joshua Ford is a professional has a science degree from the Plymouth University and has diverse experience in the scientific and private sectors. He has been the Wales Cancer Research Centre since early 2019.
As project support, his roles include coordinating meetings and internal and external events, assisting reports of publications, research awards and funding granted to the university to inform key stakeholders of the Centre’s progress.
Nichola is a Senior Lecturer in Physiotherapy at the School of Healthcare Sciences Cardiff University. Her research interests include physical activity and self-management in cancer and chronic respiratory conditions such as COPD. She co-leads the Active Health Research Theme within the School of Healthcare Sciences and co-leads the South Wales division of the Council for Allied Health Professions Research (CAHPR).
Nichola completed her PhD in 2011 evaluating systemic manifestations of chronic respiratory disease and changes with pulmonary rehabilitation. She has worked with Tenovus to evaluate the Sing with Us Choir using a mixed-methods approach and is currently developing home based physical activities for lung cancer alongside teaching and supervision of undergraduate, postgraduate students.
Deya is a Professor of Molecular Medicine, a Fellow of the HEA and Chair of Research Ethics & Governance at Swansea University Medical School. She serves as editorial member of several journals in the areas of reproductive medicine and oncology. Deya is the Regional non-clinical Champion for South West Wales within the Wales Cancer Research Centre.
Deya graduated from Biochemistry at the University of Havana, Cuba (1997) and joined Prof. Rojas Pharmacology group (Centre for Pharmaceutical Chemistry, Havana) to develop preclinical studies in the areas of inflammation, tumour biology and pharmacological evaluation of Natural Products for Health Registry. Her contributions in these areas were recognised with the Cuban National Academy of Science Award. In 2000, she was the recipient of a prestigious EGIDE fellowship (2000-2002) to investigate post-translational regulation mechanisms at Drapier’s lab (ICSN-CNRS, Gif-Sur-Yvette, France). In 2003 she joined Prof. Conlan’s group at Swansea University, working on the characterisation of transcription repression mechanisms using plant and yeast models (2003-2005); and earning her PhD in Molecular Biology (2007). Deya is a founding member of the Reproductive Biology and Gynaecological Oncology Group at Swansea University Medical School. She considers herself a translational scientist in the areas of female infertility and cancer, with the ultimate goal of developing functional platforms and bringing targeted therapies into the clinic for the benefit of patients. Her projects involve close collaborations with the NHS and the private sector in the areas of multicellular 3D-patient derived models of disease and precision medicines (Antibody Drug Conjugates and Exosomes). She is a co-PI of the CEAT-Cluster for Epigenomics and ADC therapeutics project (£2.6M), where she leads the ADC programme.
Dr Sarah Gwynne is a Consultant Clinical Oncologist specialising in upper GI cancer at the South West Wales Cancer Centre (SWWCC) in Swansea and Honorary Associate Professor at Swansea University Medical School.
Her main research interests are technical radiotherapy for oesophageal cancer and radiotherapy trial quality assurance. She is a member of the National Radiotherapy Trials Quality Assurance Group, CTRAD and the Royal College of Radiologists Academic Committee. These groups encourage the development and safe running of high quality radiotherapy research in the UK.
She has been the lead local investigator for multiple trials in GI cancers and is radiotherapy research lead in for the SWWCC and oversees a radiotherapy research fellow programme there. She also sits on the Trial Management Groups of national oesophageal radiotherapy trials leading on aspects of QA.
Angela joined the centre in September 2020 to focus on the set up of Early Phase Trials and to support the centre as it enters its next quinquennium.
Angela has over 5 years experience working in the NHS in Research Governance and as a Clinical Trials Administrator, specialising in Lung, Neo-Natal and Haematology Studies.
Julie was a Research Partner at the centre for four years before taking up the Lead Lay Research Partner position in 2020. Her interests and experience within the cancer field lie mainly in the bowel cancer area and in prevention and early diagnosis of cancer generally, and her involvement is both within Wales and in some of the wider UK cancer research activities.
Her activities related to Wales Cancer Research include:
Jane is co-lead for the cancer nurse and allied health professional researcher community of the Wales Cancer Research Centre (WCRC). A nurse academic, Jane is also lead for the Health Sciences Cancer Research Group, Cardiff University and co-founder and lead for the All Wales Cancer Nurse and Allied Health Professional Research Network. She has an established track record in cancer care and palliative care research, with over 100 peer-reviewed publications. Her expertise is supportive care in cancer cachexia. Her interests include understanding how supportive care can improve treatment outcomes and patient experience. She is currently a member of the National Cancer Research Institute (NCRI) Cancer and Nutrition Collaborative and the Knowledge and Dissemination Committee, International Society of Nurses in Cancer Care.
Stephen is employed by Betsi Cadwaladr University Health Board (BCUHB), as the Head of the North Wales Clinical Research Centre (NWCRC), based at Wrexham. He is Chair of the BCUHB Research & Innovation North East Wales Board, and since January 2020, Stephen has held the position of Regional Champion: North Wales (non-clinical) within the Wales Cancer Research Centre.
Professionally, Stephen is a Professor of Biomedical Science affiliated with Wrexham Glyndwr University (0.4WTE), a Fellow member of the Institute of Biomedical Science (IBMS), a Chartered Scientist (CSci) affiliated with the Science Council, a Fellow of the Higher Education Authority (FHEA), and a Biomedical Scientist affiliated with the Health & Care Professions Council (HCPC).
In January 2014, Stephen co-founded the North Wales & North West Urological Research Centre (NW2URC), with Professor Iqbal Shergill (BCUHB Consultant Urological Surgeon). This research centre is the main vehicle for his current research work, which primarily involves investigating patients with cancer of the bladder and prostate. Since 2018, Stephen has been working with Dr Pasquale Innominato (BCUHB, Medical Oncologist) and colleagues from the Universities of Oxford (Professor Helen Byrne) and Warwick (Professor Leandro Pecchia), to evaluate the role of the circadian rhythm for optimising therapy in cancer patients.
Stephen is dedicated to performing and supporting cancer research for the benefits of patients and the public in Wales and beyond.